Literature DB >> 33630215

Circ_0006948 Contributes to Cell Growth, Migration, Invasion and Epithelial-Mesenchymal Transition in Esophageal Carcinoma.

Meng Yue1, Yanxia Liu2, Taiyang Zuo3, Yakun Jiang4, Jianmei Pan4, Shuhong Zhang4, Xingjie Shen4.   

Abstract

BACKGROUND: Circular RNAs (circRNAs) can act as promoters or inhibitors in cancer progression. Has_circ_0006948 (circ_0006948) was reported to aggravate the malignant behaviors of esophageal carcinoma (EC). AIMS: This study focused on investigating the molecular mechanism of circ_0006948 in EC progression.
METHODS: The quantitative real-time polymerase chain reaction was performed to detect the expression of circ_0006948, microRNA-4262 (miR-4262) and fibronectin type III domain containing 3B (FNDC3B). Cell growth analysis was conducted by Cell Counting Kit-8 and colony formation assays. Cell migration and invasion were assessed by transwell assay. Epithelial-mesenchymal transition (EMT)-associated proteins and FNDC3B protein expression were assayed using western blot. Dual-luciferase reporter and RNA pull-down assays were performed to validate the target combination. Xenograft tumor assay was used for investigating the role of circ_0006948 in vivo.
RESULTS: Circ_0006948 was upregulated in EC tissues and cells. Downregulating the expression of circ_0006948 or FNDC3B repressed cell growth, migration, invasion and EMT in EC cells. Target analysis indicated that miR-4262 was a target for circ_0006948 and FNDC3B was a downstream gene for miR-4262. Moreover, circ_0006948 could affect the expression of FNDC3B via sponging miR-4262. The effects of si-circ_0006948#1 on EC cells were partly restored by miR-4262 inhibition or FNDC3B overexpression. In addition, circ_0006948 also facilitated EC tumorigenesis in vivo by targeting the miR-4262/FNDC3B axis.
CONCLUSION: Taken together, circ_0006948 functioned as an oncogenic factor in EC by the miR-4262-mediated FNDC3B expression regulation.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Circ_0006948; Esophageal carcinoma; FNDC3B; Tumor progression; miR-4262

Mesh:

Substances:

Year:  2021        PMID: 33630215     DOI: 10.1007/s10620-021-06894-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

Review 1.  Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries.

Authors:  María José Domper Arnal; Ángel Ferrández Arenas; Ángel Lanas Arbeloa
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 2.  Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role.

Authors:  Parisa Naeli; Mohammad Hossein Pourhanifeh; Mohammad Reza Karimzadeh; Zahra Shabaninejad; Ahmad Movahedpour; Hossein Tarrahimofrad; Hamid Reza Mirzaei; Hassan Hassani Bafrani; Amir Savardashtaki; Hamed Mirzaei; Michael R Hamblin
Journal:  Crit Rev Oncol Hematol       Date:  2019-12-20       Impact factor: 6.312

Review 3.  Esophagus and Gastrointestinal Junction Tumors.

Authors:  Saba Kurtom; Brian J Kaplan
Journal:  Surg Clin North Am       Date:  2020-04-11       Impact factor: 2.741

Review 4.  Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.

Authors:  Fazlur Rahman Talukdar; Massimiliano di Pietro; Maria Secrier; Markus Moehler; Katrin Goepfert; Sheila Soares Coelho Lima; Luis Felipe Ribeiro Pinto; Denver Hendricks; Mohamed Iqbal Parker; Zdenko Herceg
Journal:  Ann N Y Acad Sci       Date:  2018-06-19       Impact factor: 5.691

Review 5.  Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.

Authors:  Robin Park; Stephen Williamson; Anup Kasi; Anwaar Saeed
Journal:  Anticancer Res       Date:  2018-10       Impact factor: 2.480

Review 6.  Surgical treatment of esophageal cancer in the era of multimodality management.

Authors:  Alicia S Borggreve; B Feike Kingma; Serg A Domrachev; Mikhail A Koshkin; Jelle P Ruurda; Richard van Hillegersberg; Flavio R Takeda; Lucas Goense
Journal:  Ann N Y Acad Sci       Date:  2018-05-15       Impact factor: 5.691

Review 7.  Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.

Authors:  Yuhang Xiao; Min Su; Wei Ou; Hui Wang; Bo Tian; Junliang Ma; Jinming Tang; Jie Wu; Zhining Wu; Wenxiang Wang; Yong Zhou
Journal:  Biomed Pharmacother       Date:  2019-07-11       Impact factor: 6.529

8.  Comparative study of esophagectomy, endoscopic therapy, and radiotherapy for cT1N0M0 esophageal cancer in elderly patients: A SEER database analysis.

Authors:  Jianjun Qin; Yinjie Peng; Weipeng Chen; Haibo Ma; Yan Zheng; Yin Li; Jun Wang
Journal:  Thorac Cancer       Date:  2019-06-14       Impact factor: 3.500

Review 9.  Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.

Authors:  Qingqing Feng; Hongli Zhang; Denglin Yao; Wei-Dong Chen; Yan-Dong Wang
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

View more
  5 in total

1.  Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma.

Authors:  Ulrich H Weidle; Tatjana Sela; Ulrich Brinkmann; Jens Niewoehner
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

2.  Exosomal circRNA FNDC3B promotes the progression of esophageal squamous cell carcinoma by sponging miR-490-5p and regulating thioredoxin reductase 1 expression.

Authors:  Bo Tang; Qingfeng Zhang; Kui Liu; Yun Huang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  The abnormal expression of circ-ARAP2 promotes ESCC progression through regulating miR-761/FOXM1 axis-mediated stemness and the endothelial-mesenchymal transition.

Authors:  Pei Xu; Lei Wang; Qingtao Liu; Pengkai Gao; Fengqing Hu; Xiao Xie; Lianyong Jiang; Rui Bi; Fangbao Ding; Qi Yang; Haibo Xiao
Journal:  J Transl Med       Date:  2022-07-16       Impact factor: 8.440

4.  Circ_0000442 functions as a tumor repressor in breast cancer by impacting miR-1229-3p and upregulating ZBTB1.

Authors:  Jingyu Liu; Jianhui Liu
Journal:  Mamm Genome       Date:  2022-04-08       Impact factor: 3.224

5.  CircATIC inhibits esophageal carcinoma progression and promotes radiosensitivity by elevating RHCG through sponging miR-10-3p.

Authors:  Kai Zhang; Ruitai Fan; Deyao Zhao; Peipei Liu; Zheng Yang; Junqi Liu; Song Zhang; Shilei Rao; Yang Wang; Lixin Wan
Journal:  Thorac Cancer       Date:  2022-03-20       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.